Highlights
NASDAQ: ACRS       Aclaris Therapts
Last Price Today's Change   Day's Range   Trading Volume
3.82   -0.20 (4.98%)  3.61 - 4.14  304,300

Overview

 
Avg Volume (4 weeks):697,270
4 Weeks Range:2.52 - 5.04
4 Weeks Price Volatility (%):
51.59%
52 Weeks Range:0.70 - 5.04
52 Weeks Price Volatility (%):
71.89%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1994  6612  492  172 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.039 
 GE 7.42+0.32 
 AAPL 111.20-5.40 
 SPY 326.66-11.56 
 SQQQ 24.65+2.59 
 UVXY 23.14+4.07 
 NIO 27.51-0.93 
 XLF 23.61-0.62 
 F 7.70-0.22